Table of Contents - Volume 12, Issue 18



September 1, 2021

View the latest oncology-focused research published in this week’s issue of Oncotarget, Volume 12, Issue 18. Priority Research Paper (Cover) - “Normal tissue and tumor microenvironment adaptations to aerobic exercise enhance doxorubicin anti-tumor efficacy and ameliorate its cardiotoxicity in retired breeder mice” Research Paper - “Selinexor, a selective inhibitor of nuclear export, enhances the anti-tumor activity of olaparib in triple negative breast cancer regardless of BRCA1 mutation status” Research Paper - “Pim kinase inhibitor co-treatment decreases alternative non-homologous end-joining DNA repair and genomic instability induced by topoisomerase 2 inhibitors in cells with FLT3 internal tandem duplication” Research Paper - “Impact factor and citation metrics in phase III cancer trials” Research Paper - “Inhibition of the MAP2K7-JNK pathway with 5Z-7-oxozeaenol induces apoptosis in T-cell acute lymphoblastic leukemia” Research Paper - “Correlation between PD-L1 expression and MET gene amplification in patients with advanced non–small-cell lung cancer and no other actionable oncogenic driver” Research Paper - “Effect of hypertension and medication use regularity on postoperative delirium after maxillofacial tumors radical surgery” Review - “Anti-aging: senolytics or gerostatics (unconventional view)” Case Report - “The value of comprehensive genomic sequencing to maximize the identification of clinically actionable alterations in advanced cancer patients: a case series” Editorial - “Juvenile polyposis without a germline variant in SMAD4/BMPR1A: defining a clinically distinct polyposis syndrome” (PDF Download) Research Perspective - “Targeting cancer stem cells via integrin β4” Keywords - aerobic exercise, breast cancer, selinexor, Pim kinase, journal impact factor, T-ALL, non–small-cell lung cancer, oral tumor surgery, geroscience, senolytics, RNA sequencing, cancer stem cells, cancer, science, research, oncology About Oncotarget Oncotarget is a bi-weekly, peer-reviewed, open access biomedical journal covering research on all aspects of oncology. To learn more about Oncotarget, please visit or connect with: SoundCloud - Facebook - Twitter - LinkedIn - Instagram - YouTube - Pinterest - Reddit - Oncotarget is published by Impact Journals, LLC. Please visit or connect with @ImpactJrnls Media Contact MEDIA@IMPACTJOURNALS.COM 18009220957

Cancer Research

Keep up to date with all your favourite videos and channels.

Get personalised notifications on new releases and channel content by subscribing to the LabTube eNewsletter.